Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.

Our mission is to support the development of Clinical Psychology, both as a profession and as a body of knowledge and skills. By working collaboratively with a number of organisations including the ...

A pheochromocytoma is an intra-adrenal paraganglioma ... procedures Localization studies should only follow reasonable clinical and/or biochemical evidence of a tumor Although CT and MRI have ...

Long-term periodic follow-up, therefore, remains recommended for all cases of pheochromocytoma or paraganglioma.

Approval was based on results of the VIVID-1 study, which found that Omvoh demonstrated significant clinical remission and endoscopic ... Crohn's disease have shared with us how truly disruptive ...

Creating two distinct classifications of “clinical obesity” and “pre-clinical obesity” would provide more accurate diagnosis and more personalised treatment, it argued.

bnHealth Promotion and Obesity Management Unit, Department of Pathophysiology, Faculty of Medical Science, Medical University of Silesia, Katowice, Poland boSchool of Public Health, Tongji Medical ...

This Commission sought to define clinical obesity as a condition of illness that, akin to the notion of chronic disease in other medical specialties, directly results from the effect of excess ...